Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis

World Journal of Gastroenterology

Volumn 18, Issue 24, 2012, Pages 3119-3128

  Yan, Ze Hui ^a   Fan, Yi ^a   Wang, Xiao Hong ^a   Mao, Qing ^a   Deng, Guo Hong ^a   Wang, Yu Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Human leukocyte antigens; Meta analysis; Polymorphism

Indexed keywords

HLA DR ANTIGEN;

ALLELE; ARTICLE; CHINESE; GENETIC POLYMORPHISM; HEPATITIS B; HUMAN; META ANALYSIS; PERSISTENT VIRUS INFECTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VIRAL CLEARANCE;

EID: 84863941948     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i24.3119     Document Type: Article

References (46)

1. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003; 362: 2089-2094
2. Segal S, Hill AV. Genetic susceptibility to infectious disease. Trends Microbiol 2003; 11: 445-448
3. Frodsham AJ. Host genetics and the outcome of hepatitis B viral infection. Transpl Immunol 2005; 14: 183-186
4. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC, Kwang TY, Hsu ST, Lin SY, Hsu LC. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989; 9: 737-741
5. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, Tur-Kaspa R, Klein T. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003; 98: 144-150
6. Höhler T, Kruger A, Gerken G, Schneider PM, Meyerzum Büschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998; 111: 579-582
7. Suneetha PV, Sarin SK, Goyal A, Kumar GT, Shukla DK, Hissar S. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. J Hepatol 2006; 44: 856-863
8. Chong WP, To YF, Ip WK, Yuen MF, Poon TP, Wong WH, Lai CL, Lau YL. Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology 2005; 42: 1037-1045
9. Deng G, Zhou G, Zhai Y, Li S, Li X, Li Y, Zhang R, Yao Z, Shen Y, Qiang B, Wang Y, He F. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 2004; 40: 318-326
10. Deng G, Zhou G, Zhang R, Zhai Y, Zhao W, Yan Z, Deng C, Yuan X, Xu B, Dong X, Zhang X, Zhang X, Yao Z, Shen Y, Qiang B, Wang Y, He F. Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 2008; 134: 716-726
11. Yan Z, Tan W, Zhao W, Dan Y, Wang X, Mao Q, Wang Y, Deng G. Regulatory polymorphisms in the IL-10 gene promoter and HBV-related acute liver failure in the Chinese population. J Viral Hepat 2009; 16: 775-783
12. Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O'Brien SJ. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011; 53: 422-428
13. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H, Puseenam A, Sura T, Daigo Y, Chayama K, Chantratita W, Nakamura Y, Matsuda K. A genome-wideassociation study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41: 591-595
14. Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 2005; 41: 1383-1390
15. Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007; 13: 1770-1787
16. Höhler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, Löhr HF, Schneider PM, Meyer zum Büschenfelde KH, Rittner C. HLA-DRB1*;1301 and *;1302 protect against chronic hepatitis B. J Hepatol 1997; 26: 503-507
17. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003; 77: 12083-12087
18. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, Kim YS, Park K, Kim DK, Moon YM. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000; 31: 1371-1373
19. Wu YF, Wang LY, Lee TD, Lin HH, Hu CT, Cheng ML, Lo SY. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J Med Virol 2004; 72: 17-25
20. Meng XQ, Chen HG, Ma YL, Liu KZ. Influence of HLA class II molecules on the outcome of hepatitis B virus infection in population of Zhejiang Province in China. Hepatobiliary Pancreat Dis Int 2003; 2: 230-233
21. Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J Gastroenterol 2003; 9: 2221-2225
22. Shen JJ, Ji Y, Guan XL, Huang RJ, Sun YP. [The association of HLA-DRB110 with chronic hepatitis B in Chinese patients]. Zhonghua Weishengwuxue He Mianyixue Zazhi 1999; 19: 58-59
23. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999; 28: 1-9
24. Mays N, Pope C, Popay J. Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field. J Health Serv Res Policy 2005; 10 Suppl 1: 6-20
25. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
27. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748
28. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-129
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560
30. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988; 7: 889-894
31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
32. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065-1069
33. Akcam Z, Sunbul M, Durupinar B, Eroglu C, Esen S, Leblebicioglu H. Tissue types as prognostic risk factor in hepatitis B virus infection. Indian J Gastroenterol 2002; 21: 139-141
34. Zhang SY, Gu HX, Li D, Yang SF, Zhong ZH, Li XK, Jin X. Association of human leukocyte antigen polymorphism with hepatitis B virus infection and genotypes. Jpn J Infect Dis 2006; 59: 353-357
35. Yang G, Liu J, Han S, Xie H, Du R, Yan Y, Xu D, Fan D. Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China. Tissue Antigens 2007; 69: 170-175
36. Zhu XL, Du T, Li JH, Lu LP, Guo XH, Gao JR, Gou CY, Li Z, Liu Y, Li H. Association of HLA-DQB1 gene polymorphisms with outcomes of HBV infection in Chinese Han population. Swiss Med Wkly 2007; 137: 114-120
37. Hwang SH, Sohn YH, Oh HB, Hwang CY, Lee SH, Shin ES, Lee KJ. Human leukocyte antigen alleles and haplotypes associated with chronicity of hepatitis B virus infection in Koreans. Arch Pathol Lab Med 2007; 131: 117-121
38. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N. Association of HLA-DRB1*;13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 2007; 14: 841-848
39. Cho SW, Cheong JY, Ju YS, Oh do H, Suh YJ, Lee KW. Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype level. J Korean Med Sci 2008; 23: 838-844
40. Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M, Taeb J, Aghakhani A, Gachkar L, Velayati AA. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J Gastroenterol Hepatol 2008; 23: 1716-1721
41. Albayrak A, Ertek M, Tasyaran MA, Pirim I. Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey. Biochem Genet 2011; 49: 258-269
42. Chen HG, Jiang GF, Meng XQ, Ma YL, Liu KZ. [Preliminary report on the influence of HLA class II molecules on outcome of hepatitis B virus infection in Zhejiang district]. Zhonghua Chuanranbing Zazhi 2002; 20: 164-167
43. Lu LP, Li XW, Liu Y, Sun GC, Chen ZH, Zhu XL, Hu QY, Li H. [Association of haplotype formed on HLA-DRB1 and HLA-DQA1 alleles with outcomes of hepatitis B virus infection]. Zhonghua Yixue Yichuanxue Zazhi 2006; 23: 427-430
44. Song MS, Li HW, Peng HY, Duan BN, Chen H, Xu LQ. [Association of polymorphism on HLA-DRB1*;04 alleles with outcome of hepatitis B virus infection]. Zhonghua Yixue Yichuanxue Zazhi 2007; 24: 467-469
45. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-463
46. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007; 335: 914-916